Advertisement
Screener

United Therapeutics Corporation (UTHR) Repayments of Convertible Debt

2.6 / 5 stars · 62/120 Roast Me

United Therapeutics Corporation Repayments of Convertible Debt

United Therapeutics Corporation (UTHR) reported Repayments of Convertible Debt of $8.80 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-27.

Discontinued › Cash Flow › Financing Activities

us-gaap:RepaymentsOfConvertibleDebt · last filed 2019-02-27

  • United Therapeutics Corporation repayments of convertible debt for fiscal 2016 was $8.80M, a 93.39% decline from fiscal 2015.
  • United Therapeutics Corporation repayments of convertible debt for fiscal 2015 was $133.20M, a 25.08% decline from fiscal 2014.
  • United Therapeutics Corporation repayments of convertible debt for fiscal 2014 was $177.80M, a 13369.70% increase from fiscal 2013.
  • United Therapeutics Corporation repayments of convertible debt for fiscal 2013 was $1.32M, a 32.13% increase from fiscal 2012.
Period endRepayments of Convertible Debt 12 monthRepayments of Convertible Debt 12 month as first filed
2016-12-31$8.80M
10-K · filed 2019-02-27
2015-12-31$133.20M
10-K · filed 2018-02-21
$133.15M
10-K · filed 2016-02-25
2014-12-31$177.80M
10-K · filed 2017-02-22
2013-12-31$1.32M
10-K · filed 2016-02-25
2012-12-31$999.00K
10-K · filed 2015-02-24
2011-12-31$251.04M
10-K · filed 2014-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Viatris Inc (VTRS)United States$20.008B-0.00
Royalty Pharma plc (RPRX)United States$22.628B
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17